References
- Sohn CH. Type and treatment of toxic mushroom poisoning in Korea. J Korean Med Assoc 2015; 58:818-24. https://doi.org/10.5124/jkma.2015.58.9.818
- Smith MR, Davis RL. Mycetismus: a review. Gastroenterol Rep 2016;4:107-12. https://doi.org/10.1093/gastro/gov062
-
Mengs U, Pohl RT, Mitchell T.
$Legalon^{(R)}$ SIL: the antidote of choice in patients with acute hepatotoxicvity from amatoxins poisoning. Curr Pharm Biotechnol 2012;13:1964-70. https://doi.org/10.2174/138920112802273353 - Ye Y, Liu Z. Management of Amanita phalloides poisoning; A literature review and update. J Crit Care 2018;46:17-22. https://doi.org/10.1016/j.jcrc.2018.03.028
- Garcia J, Costa VM, Carvalho A, Baptista P, de Pinho PG, de Lourdes Bastos M, et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food Chem Toxicol 2015;86:41-55. https://doi.org/10.1016/j.fct.2015.09.008
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12. https://doi.org/10.1016/j.jclinepi.2009.06.005
- Available at: http://www.sign.ac.uk/checklists-and-notes.html. Accessed April 13, 2018.
- Berger KJ, Guss DA. Mycotoxins revisited: part I. J Emerg Med 2005;28:53-62. https://doi.org/10.1016/j.jemermed.2004.08.013
- Polyak SJ, Oberlies NH, Pecheur EI, Dahari H, Ferenci P, Pawlotsky JM. Silymarin for HCV infection. Antivir Ther 2013;18:141-7. https://doi.org/10.3851/IMP2402
- Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver disease. Drugs 2001;61:2035-63. https://doi.org/10.2165/00003495-200161140-00003
- Post-White J. Advances in the use of milk thistle. Intergrr Cancer Ther 2007;6:104-9. https://doi.org/10.1177/1534735407301632
- Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev 2005;2:CD003620.
- Zuber R, Modriansky M, Dvorak Z, Rohovsky P, Ulrichova J, Simanek V, et al. Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytother Res 2002;16:632-8. https://doi.org/10.1002/ptr.1000
- Enjalbert F, Rapior S, Nouguier-Soule J, Guillon S, Amouroux N, Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 2002;40:715-57. https://doi.org/10.1081/CLT-120014646
- Poucheret P, Fons F, Dore JC, Michelot D, Rapior S. Amatoxin poisoning treatment decision-making: Pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis. Toxicon 2010;55:1338-45. https://doi.org/10.1016/j.toxicon.2010.02.005
- Garcia J, Costa VM, Carvalho AT, Silvestre R, Duarte JA, Dourado DF, et al. A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B. Arch Toxicol 2015;89:2305-23. https://doi.org/10.1007/s00204-015-1582-x
- Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus--a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-90. https://doi.org/10.1016/S0168-8278(03)00468-9
- Pillukat MH, Schomacher T, Baier P, Gabriels G, Pavenstadt H, Schmidt HH. Early initiation of MARS(R) dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation. Ann Hepatol 2016;15:775-87.
- Available at: http://drug.mfds.go.kr/html/index.jsp. Accessed May 20, 2018.
- Zilker TR, Felgenhauer NJ, Michael H, Strenge-Hesse A. Grading of severity and therapy of 154 cases of Amanita poisoning. Vet Hum Toxicol 1993;35:331-6.
- Zilker TH. Prognosis and treatment of amatoxin poisoning. Clin Toxicol 2009;47:467.
- Ganzert M. Felgenhauer N. Schuster T, Eyer F, Gourdin C, Zilker T. Amanita poisoning-conparison of silibinin with a combination silibinin and penicillin. Dtsch Med Wochenschr 2008;133:2261-7. https://doi.org/10.1055/s-0028-1091268
- Rengstorff DS, Osorio RW, Bonacini M. Recovery from severe hepatitis caused by mushroom poisoning without liver transplantation. Clin Gastroenterol Hepatol 2003;1:392-6. https://doi.org/10.1053/S1542-3565(03)00179-4
- Ahishali E, Boynuegri B, Ozpolat E, Surmeli H, Dolapcioglu C, Dabak R, et al. Approach to mushroom intoxication and treatment: can we decrease mortality? Clin Res Hepatol Gastroenterol 2012;36:139-45. https://doi.org/10.1016/j.clinre.2011.11.004
- Robert DM, Hall MJ, Falkland MM, Strasser SI, Buckley NA. Amanita phalloides poisoning and treatment with silibinin in the Australian capital territory and New South Wales. Med J Austr 2013;198:43-7. https://doi.org/10.5694/mja12.11180
- Akin A, Keskek SO, Kilic DA, Aliustaoglu M, Keskek NS. The effect of N-acetylcysteine in patients with Amanita phalloides intoxication. J Drug Metab Toxicol 2013;4:1-3.
- Krenova M, Pelclova D, Navratil T. Survey of Amanita phalloides poisoning: clinical findings and follow-up evaluation. Hum Exp Toxicol 2007;26:955-61. https://doi.org/10.1177/0960327107085832
- Fix OK, Davern TJ, Doo E, Zaman A, Ganger DR, Reddy R, et al. Acute liver failure due to mushroom poisoning in the United States: Results from the ALFSG registry. Hepatology 2011;54:497A.
- Karvellas CJ, Tillman H, Leung AA, Lee WM, Schilsky ML, Hameed B, et al. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int 2016;36:1043-50. https://doi.org/10.1111/liv.13080
- Trakulsrichai S, Sriapha C, Tongpoo A, Udomsubpayakul U, Wongvisavakorn S, Srisuma S, et al. Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning. Int J Gen Med 2017;10:395-400. https://doi.org/10.2147/IJGM.S141111